CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 28 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,465,000 | -41.4% | 682,940 | -0.1% | 0.10% | -48.5% |
| Q3 2016 | $4,210,000 | +76.8% | 683,375 | +6.2% | 0.20% | +108.5% |
| Q2 2016 | $2,381,000 | -26.6% | 643,580 | 0.0% | 0.09% | -31.9% |
| Q1 2016 | $3,244,000 | -36.4% | 643,580 | 0.0% | 0.14% | -33.3% |
| Q4 2015 | $5,104,000 | +0.4% | 643,580 | +2.4% | 0.21% | +5.1% |
| Q3 2015 | $5,084,000 | -43.6% | 628,482 | -14.8% | 0.20% | -34.3% |
| Q2 2015 | $9,012,000 | – | 738,055 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $17,602,000 | 13.52% |
| Clarus Ventures, LLC | 2,752,488 | $16,955,000 | 10.42% |
| Cormorant Asset Management, LP | 800,000 | $4,928,000 | 0.54% |
| GREAT POINT PARTNERS LLC | 250,000 | $1,540,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 387,943 | $2,390,000 | 0.39% |
| Camber Capital Management LP | 1,000,000 | $6,160,000 | 0.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 683,375 | $4,210,000 | 0.20% |
| TLP GROUP LLC | 25,920 | $160,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 100,000 | $616,000,000 | 0.10% |
| FT Options LLC | 17,736 | $109,000 | 0.09% |